Sort
16,179 grants matching “malaria”
Malaria Transmission Blocking Vaccine Discovery
$1,301,961Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Vector-Borne Diseases: Biology Of Vector Host Relationship
$1,301,779Jose Ribeiro · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Role of Data Streams In Informing Infection Dynamics in Africa- INFORM Africa
$1,300,000Alash'le G. Abimiku · Institute Of Human Virology · U54 · FY2023 · TW
Role of Data Streams In Informing Infection Dynamics in Africa- INFORM Africa
$1,300,000Alash'le G. Abimiku · Institute Of Human Virology · U54 · FY2024 · TW
Role of Data Streams In Informing Infection Dynamics in Africa- INFORM Africa
$1,300,000Alash'le G. Abimiku · Institute Of Human Virology · U54 · FY2021 · TW
Role of Data Streams In Informing Infection Dynamics in Africa- INFORM Africa
$1,300,000Alash'le G. Abimiku · Institute Of Human Virology · U54 · FY2022 · TW
ALABAMA/ZAMBIA HIV VACCINE CLINICAL TRIALS UNIT (HVTU)
$1,299,748University Of Alabama At Birmingham · U01 · FY2004 · AI
Biologically informed design of CD8+ T cell-dependent pre-erythrocytic stage malaria vaccines
$1,298,298Stefan H.i. Kappe · Seattle Children'S Hospital · U01 · FY2022 · AI
BLOOD GROUP ANTIGENS IN HEALTH AND DISEASE
$1,294,342New York Blood Center · P50 · FY2001 · HL
Southeast Asia Malaria Research Center
$1,294,213Liwang Cui · University Of South Florida · U19 · FY2019 · AI
International Center for Excellence in Research (ICER) in Uganda: Impact of ARVs
$1,293,832Thomas Quinn · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Focal mass drug administration (fMDA) to reduce Plasmodium vivax transmission, a pragmatic cluster randomized controlled trial in Peru
$1,293,493Michelle Sang Hsiang · University Of California, San Francisco · U01 · FY2022 · AI
Mali International Center for Excellence in Research: Parasitic Infectious Diseases and their Vectors
$1,292,865Carole Long · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Host-parasite-vector interactions during malaria transmission
$1,292,294Joel Vega-Rodriguez · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Southeast Asia Malaria Research Center
$1,289,590Liwang Cui · University Of South Florida · U19 · FY2021 · AI
Integrated genomics research in parasitic tropical diseases
$1,289,587Joana Carneiro Da Silva · University Of Maryland Baltimore · U19 · FY2015 · AI
A Vaccine for Schistosomiasis, "SchistoShield"
$1,288,089Darrick Albert Carter · Pai Life Sciences, Inc. · R44 · FY2018 · AI
Studies on Transfer RNA
$1,287,188Dieter G Soll · Yale University · R01 · FY2012 · GM
Studies on Transfer RNA
$1,287,188Dieter G Soll · Yale University · R01 · FY2011 · GM
Studies on Transfer RNA
$1,286,297Dieter G Soll · Yale University · R01 · FY2009 · GM
Single-molecule sequence assembly and analysis
$1,284,525Adam Phillippy · National Human Genome Research Institute · ZIA · FY2017 · HG
Integrative Omics of HepB Vaccine Response in Co-Infection with Parasites
$1,284,141Elias K Haddad · Drexel University · U19 · FY2018 · AI
Enhancing immunity to malaria in young children with effective chemoprevention
$1,283,030Prasanna Jagannathan · Stanford University · U01 · FY2021 · AI
Vaccine and Treatment Evaluation Units
$1,282,926Nadine Georges Rouphael · Emory University · UM1 · FY2025 · AI
Expanding the breadth, magnitude, and durability of PfSPZ vaccines by creating multi-strain vaccines, designer hybrid and genetically altered parasite vaccines and use of a unique adjuvant.
$1,279,157B. Kim Lee Sim · Sanaria, Inc. · U01 · FY2022 · AI